Advent Partners GPE VIII Limited Partnership
CIK 1676941 · last filed 2023-07-06
Advent Partners GPE VIII Limited Partnership is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $66.5M of FWRG on Jul 6, 2023. Across all open-market trades the lifetime net is −$1.36B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $377.0M across reported positions. The firm reports its address in Boston, MA. 22 SEC filings were submitted jointly with ADVENT INTERNATIONAL, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FWRG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
800 BOYLSON STREET, SUITE 3300
BOSTON, MA 02199
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FWRG | 10%+ Owner | 34,089,784 | $11.06 | $377.03M | -$993.58M | 3 | 2023-07-06 |
| Syneos Health, Inc. (SYNH) Delisted | 10%+ Owner | 6,307,489 | $42.98 | $271.10M | -$363.82M | 1 | 2021-05-18 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-06 | FWRG | Sell (S) | −4,050,000 | -$66.52M | EDGAR |
| 2023-06-15 | FWRG | Sell (S) | −24,000,000 | -$394.18M | EDGAR |
| 2022-09-21 | FWRG | Sell (S) | −36,000,000 | -$532.89M | EDGAR |
| 2021-05-18 | Syneos Health, Inc. (SYNH) Delisted | Sell (S) | −4,489,420 | -$363.82M | EDGAR |
| 2020-04-01 | — | Buy (P) | +287,744,139 | $7.80B |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.